September 18, 2012

Denmark's pharmaceutical firm, Pharmacosmos, has released Uniferon, its iron supplement for piglets, into Portugal's pig production market.

A recent introduction of the injectable iron supplement, Uniferon, to pig producers in Portugal is yet another step into the world for the Danish pharmaceutical company, Pharmacosmos.

Pharmacosmos specialises iron deficiency treatments for both humans and animals, and the company's Uniferon, which is an all-natural injectable iron supplement for newborn piglets, is in use by pig farmers throughout the world.

"Pig production in Portugal is under change from smaller to larger herders. Hence, the pig industry, in general, is becoming increasingly focused on global best practice and hence, also the generally accepted standard of administering iron to new-born piglets to promote optimal growth and general health as well as avoiding detrimental anaemia. Pig producers in the Baltics are thus becoming increasingly demanding and we are glad that we are now able to support their efforts," said Jens Fabricius, Vice President, Marketing & Business Operations at Pharmacosmos A/S.

Uniferon is marketed through Laboratório Sorológico, a Portuguese veterinary pharmaceutical company belonging to the Medinfar Group and dedicated to the production and marketing of veterinary pharmaceuticals and equipment. The company was founded about 80 years ago and offers a wide range of pharmaceuticals, vaccines and complementary feed for different animal species, investing in technological development and improvement of production processes and quality control.